Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

US FDA classifies Medtronic’s sutureless connector safety alert as a Class I recall

Medtronic : 26 September, 2008  (Company News)
The US Food and Drug Administration has classified Medtronic’s safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems as a Class I recall.
The notification relates to the improper connection of its sutureless connector intrathecal catheters (referred to as SC catheters). The affected products include the following models; INDURA 1P Intrathecal Catheter, model 8709SC, Intrathecal Catheter, model 8731SC, Sutureless Pump Connector Revision Kit, model 8578, and Intrathecal Catheter Pump Segment Revision Kit, model 8596SC.

In June 2008, Medtronic informed the FDA and clinicians worldwide that it had received reports of infusion system difficulties that were attributed to two problems.

The first problem was the occlusion or improper alignment between the catheter’s connector and the pump’s port. The second problem was the disconnection of the Catheter from the pump. Neither Medtronic’s June 2008 communication, nor the FDA’s classification of it as a recall, requires the explant or return of any products to Medtronic. The FDA’s classification of Medtronic’s safety alert is consistent with the actions previously taken by Medtronic and no new action is required of physicians beyond the recommendations listed in the June 2008 letter.

To date, Medtronic has received 83 reports of infusion system difficulties worldwide that have been attributed to either an occlusion or a disconnection of the sutureless Catheter from the pump. Medtronic’s investigation indicated that the events were caused by misalignment or incomplete connection of the sutureless connector on the Catheter to the Catheter port on the pump during the Implant procedure. Analysis of the products returned indicated that when there is an occlusion (misalignment during connection), the Catheter port may become embedded in the inner wall of the connector seal, rather than aligning with the connector. Improper attachment can result in Catheter connector damage, leaks at the connection site, or Catheter disconnection some time after implant. It is critical for the connector to be properly aligned with the port during initial attachment for the Catheter to be correctly and completely connected to the pump.

The clinical signs of a possible occlusion or disconnection may include a lack of therapeutic effect, a clinically significant or fatal drug overdose or a return of underlying symptoms, and drug withdrawal symptoms. Patients receiving intrathecal baclofen therapy (Lioresal Intrathecal) are at higher risk for adverse events as baclofen withdrawal can lead to a life threatening condition if not treated promptly and effectively.

In one case, a patient died from acute baclofen withdrawal related to complications from an improperly connected catheter. A second patient death was reported after device replacement, however it was reported by the health care provider that the death was not considered to be device related. All patients experiencing an occlusion or improper connection will require a surgical procedure for correction.

Medtronic’s June 2008 physician letter provided specific recommendations for managing patients with implanted SC catheters including ongoing education of patients and caregivers of the signs and symptoms of drug underdose and withdrawal, as well as steps to take to identify an occlusion or disconnection, which requires a surgical procedure.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo